Most frequent post-vaccination effects against SARS-COV-2 in workers of a Social Security hospital, Bellavista – 2021
DOI:
https://doi.org/10.20453/renh.v14i1.5058Keywords:
Effects, vaccine, systemic, , coronavirusAbstract
An effective measure to prevent and control infection by the new SARS-CoV-2 virus is the vaccine, and its adherence is essential. Objective: To determine the most frequent post-vaccination effects against SARS-CoV-2, in the workers of a social security hospital, Bellavista - 2021, considering the systemic and local dimensions. Material and methods: A descriptive, cross-sectional study with a non-experimental design. The non-probabilistic sample was 200 people. An instrument was used for data collection, the digital data sheet prepared by the authors, according to the characteristics sheet of the Shinopharm vaccine. Results: 60.5% (121 workers) presented systemic effect and 53% (106 workers) presented local effect. The frequent systemic effect was drowsiness in 39% (78 workers) and the frequent local effect was pain in the area of application in 49% (98 workers). Likewise, an association of systemic effects with age (p≤0.01) and sex (p≤0.01) was found; and local effects with age (p=0.01). There is no evidence of
association with those infected by covid-19, systemic (p=5.31) and local (p=0.23). Conclusions: Systemic effects are more frequent than local effects. The most common systemic effect is drowsiness and the most common local effect is pain at the application site. The systemic effect is associated with age and sex. The systemic and local effect is not associated with personnel with a history of infection with COVID-19.
Downloads
References
Ministerio de Salud. Documento Técnico: Plan Nacional de vacunación contra la COVID-19. Lima:
Ministerio de Salud; 2020.
Organización Panamericana de la Salud. Situación en la region de las americas.]. Washington DC: Organización Panamericana de la Salud; 2020. (Citado el 25 de enero del 2020). Disponible en:
Organización Mundial de la Salud. Vacunas contra la COVID-19. Ginebra: Organización Mundial de
la Salud; 2020. (Citado el 25 de enero del 2020). Disponible en: https://www.who.int/es/emergencies/ diseases/novel-coronavirus-2019/covid-19-vaccines.
University of Oxford. Estadística e investigación vacunas contra el coronavirus (COVID-19). Oxford: University of Oxford; 2021. (Citado el 20 de marzo del 2021). Disponible en: https://ourworldindata.org/covid-vaccinations?country=OWID_WRL
Ministerio de Salud. Directiva sanitaria para la vacunación contra la covid-19, en la situación de
emergencia sanitaria por pandemia en el Perú. Lima:Ministerio de Salud; 2021. (Citado el 20 de marzo del
. Disponible en: https://cutt.ly/OHLIW0u
Pareja M, De León J, Navarrete PJ, Luque JC, Gonzáles JD. Detección de anticuerpos neutralizantes en profesionales de la salud vacunados contra el SARS-CoV-2. Horizonte Medico. 2021; 21(3): p. 5.
Ministerio de Salud. Directiva Sanitaria para la viglancia epidemiológica de eventos supestamente
atribuidos a la vacunación o inmunización. Lima Ministerio de Salud ; 2014. (Citado el 20 de marzo
del 2021). Disponible en: https://cutt.ly/lHLU9EV
Seguro Social de Salud del Perú. Manual de vacunación segura contra la COVID-19. [Online]. Lima: Social de Salud del Perú; 2021.(Citado el 20 de marzo del 2021). Disponible en: https://cutt.ly/EHLIhVn
Arias G F. El proyecto de investigación. Caracas:Episteme; 2012.
Congreso de la Republica del Perú. Ley de protecciónde datos personales. Lima: Ministerio de Justicia; 2011.
(Citado el 20 demarzo del 2021).Disponible en: https://www.minjus.gob.pe/wp-content/uploads/2013/04/
LEY-29733.pd11. Ministerio de Salud. Norma Técnica de Salud que establece el Esquema Nacional de Vacunación.Lima:Ministerio de Salud; 2018. (Citado el 20 de marzo del 2021). Disponible en: https://cdn.www.gob.pe/uploads/document/file/300034/d177030_opt.PDF
Ministerio de Salud. Directiva Sanitaria para la Vigilancia Epidemiológica de Eventos Supuestamente
Atribuidos a la Vacunación e Inmunización. Lima, Ministerio de Salud; 2014. (Citado el 20 de marzo del
. Disponible en: https://www.dge.gob.pe/portal/docs/tools/ESAVI08-04.pd
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Revista Enfermeria Herediana are under a Creative Commons Reconocimiento 4.0 International license.
The authors retain the copyright and grant the journal the right of first publication, with the work registered with the Creative Commons License, which allows third parties to use what is published whenever they mention the authorship of the work, and to the first publication in this magazine.
Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version published in this journal, provided they clearly indicate that the work was published in this journal.
The authors can file in the repository of their institution:
The research work or thesis of degree from which the published article derives.
The pre-print version: the version prior to peer review.
The Post-print version: final version after peer review.
The definitive version or final version created by the publisher for publication.